Accelerated Variant of Idiopathic Pulmonary Fibrosis: Clinical Behavior and Gene Expression Pattern

2007

Accelerated Variant of Idiopathic Pulmonary Fibrosis: Clinical Behavior and Gene Expression Pattern

Sample size: 114 publication 10 minutes Evidence: moderate

Author Information

Author(s): Selman Moisés, Carrillo Guillermo, Estrada Andrea, Mejia Mayra, Becerril Carina, Cisneros José, Gaxiola Miguel, Pérez-Padilla Rogelio, Navarro Carmen, Richards Thomas, Dauber James, King Talmadge E. Jr, Pardo Annie, Kaminski Naftali

Primary Institution: Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico

Hypothesis

Can 'rapid' and 'slow' progressor IPF patients be distinguished by clinical, biological, or molecular features?

Conclusion

A subgroup of IPF patients, predominantly smoking males, display an accelerated clinical course and have a gene expression pattern that is different from those with slower progression and longer survival.

Supporting Evidence

Rapid progressors had a significantly reduced survival compared to slow progressors.
There were more males and smokers in the rapid progressors group.
437 differentially expressed genes were identified between rapid and slow progressors.

Takeaway

Some people with lung disease get worse really fast, while others take a long time to get sick. This study helps us understand why that happens.

Methodology

The study analyzed clinical and molecular features of 114 IPF patients, comparing those with rapid progression (≤6 months of symptoms) to those with slow progression (≥24 months of symptoms).